GlassScriptPhysician profile
Kristen Rainear
NPI 1689662165
$83,020.21
in general payments reported to CMS, 2019-2025
22 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $9,188 · 2021: $13K · 2022: $21K · 2023: $4,164 · 2024: $417 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,300 · Food and Beverage: $1,000 · Travel and Lodging: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,300.00 |
| Food and Beverage | $1,000.48 |
| Travel and Lodging | $619.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $69,798.64 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $11,032.45 | 2019-2025 | Watchman Flx, Bodyguardian |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $592.24 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $208.95 | 2022-2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $196.20 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $163.56 | 2020-2022 | |
| Kestra Medical Technology Services, INC. | $156.21 | 2022-2025 | Assure Wcd |
| Pfizer INC. | $151.84 | 2020-2025 | |
| Medtronic Vascular, INC. | $146.38 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $118.81 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $104.40 | 2023-2024 | Inpefa |
| Abbott Laboratories | $82.76 | 2021-2022 | |
| Medtronic, INC. | $60.90 | 2021 | |
| Philips North America LLC | $55.02 | 2025 | Extended Holter, Mcot, Event |
| Sensible Medical Innovations INC | $24.25 | 2025 | Reds System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $23.48 | 2024 | Watchpatone |
| Scpharmaceuticals INC. | $21.73 | 2025 | |
| Baxter Healthcare | $20.43 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Cvrx, INC. | $18.06 | 2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $15.14 | 2019-2022 | |
| Glaxosmithkline, LLC. | $14.68 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.08 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Rainear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.